Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) price on Thursday, May 09, rose 6.99% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $9.49.
A look at the stock’s price movement, the level at last check in today’s session was $8.87. Turning to its 52-week performance, $16.62 and $4.52 were the 52-week high and 52-week low respectively. Overall, MRVI moved 10.35% over the past month.
Maravai LifeSciences Holdings Inc’s market cap currently stands at around $1.26 billion.
Analysts have a consensus estimate of 64.18M for the company’s revenue for the quarter, with a low and high estimate of 58.7M and 62.2M respectively. The average forecast suggests down to a -18.80% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 271.81M, representing a -5.90% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that MRVI is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
MRVI’s current price about 16.44% and 17.47% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 70.82, while 7-day volatility ratio is 3.36% and 4.77% in the 30-day chart. Further, Maravai LifeSciences Holdings Inc (MRVI) has a beta value of 0.05, and an average true range (ATR) of 0.43.
If we refocus on Maravai LifeSciences Holdings Inc (NASDAQ:MRVI), historical trading data shows that trading volumes averaged 2.77 million over the past 3 months. The company’s latest data on shares outstanding shows there are 132.23 million shares.
The 19.26% of Maravai LifeSciences Holdings Inc’s shares are in the hands of company insiders while institutional holders own 87.34% of the company’s shares. Current price change has pushed the stock 44.89% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the MRVI stock continues to rise going into the next quarter.
